Study #2007-0433
Phase II Trial Of Induction Therapy With Docetaxel, Cisplatin and Fluorouracil In Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma and/or Poorly Differentiated Carcinoma of the Nasal Cavity and/or Paranasal Sinuses
MD Anderson Study Status
Not Accepting
Treatment Agent
Carboplatin, Cisplatin, Docetaxel, Fluorouracil
Description
This phase II trial studies how well docetaxel, cisplatin and fluorouracil work in treating patients with previously untreated stage II-IV nasal cavity and/or paranasal sinus cancer. Drugs used in chemotherapy, such as docetaxel, cisplatin and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma, Sinonasal Undifferentiated Carcinoma, Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC V8, Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC V8, Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC V8, Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC V8
Study phase:
Phase II
Physician name:
Ehab Hanna
Department:
Head & Neck Surgery
For general questions about clinical trials:
1-844-514-2993
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.